好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

A Rare Case of Chronic Lymphocytic Inflammation with Pontine Perivascular Enhancement Responsive to Steroids in the Setting of Definitive Diagnosed Multiple Sclerosis
Multiple Sclerosis
P9 - Poster Session 9 (11:45 AM-12:45 PM)
1-014

To describe a patient with multiple sclerosis (MS) presenting with chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids (CLIPPERS).

One previous case report described CLIPPERS-like MRI findings in a patient with MS. CLIPPERS presents with subacute pontocerebellar dysfunction, <3mm nodular perivascular enhancement on MRI, and dense perivascular lymphocytic inflammation with T cell predominance. SLIPPERS has similar findings with supratentorial localization. 

NA

A 38-year-old man diagnosed with MS at age 19 with typical MRI findings and positive oligoclonal bands, presented with bilateral leg weakness, dyspnea, dysphagia, and dysphonia. MRI revealed diffuse enhancing perivascular hyperintensities in the bilateral cerebellum, pons and medullary regions suggesting CLIPPERS. A five day course of solumedrol resulted in complete radiographic resolution of the enhancement. Weakness improved quickly, but dysphonia, dysphagia and dyspnea improved slowly.  He was discharged to an acute rehabilitation hospital.  In retrospect, he had presented in 2015 with profound encephalopathy and expressive aphasia. MRI revealed diffuse cortical and subcortical perivascular enhancing lesions. When extensive serum and CSF studies, including malignancy, infectious, vasculitis, sarcoid, autoimmune and paraneoplastic evaluations were negative, a frontal lobe lesion biopsy revealed perivascular T-cell predominant infiltrate without evidence of infection. Pathology reports from CDC and local institution supported an inflammatory process and did not imply it was related to patient’s known MS.  Methylprednisolone treatment resulted in slow clinical and radiographic improvement. This event may have represented what is now known as SLIPPERS, unrecognized as the supratentorial variant of CLIPPERS was first reported a month earlier.

Patients with MS can present with CLIPPERS/SLIPPERS like events including supportive MRI, pathology, and treatment response. CLIPPERS/SLIPPERS require careful exclusion of alternative diagnoses, particularly when confounded by pre-existing MS.


Authors/Disclosures
Rachna Khanna, DO
PRESENTER
Dr. Khanna has nothing to disclose.
Martha E. Orozco Cortes, MD Dr. Orozco Cortes has nothing to disclose.
jennifer eschbacher, MD Dr. eschbacher has nothing to disclose.
Michael V. Robers, MD (Barrow Neurological Institute) Dr. Robers has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Robers has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG therapeutics. Dr. Robers has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi. Dr. Robers has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for TG Therapeutics. The institution of Dr. Robers has received research support from Bristol Myers Squibb Foundation.